Phathom Pharmaceuticals, Inc. (PHAT) stock
PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.50−0.38 (-6.46%)
Close on Nov 17, 2026Market cap $447.10MP/E –Yield –
Phathom Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Phathom Pharmaceuticals's operating cash flow for the twelve months ending Sep 30, 2026 was -$20.74M. For fiscal 2025 it was -$166.78M. The highest annual figure on record is -$1.02M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$166.78M | – |
| FY2024 | Dec 31, 2024 | -$266.77M | – |
| FY2023 | Dec 31, 2023 | -$137.58M | – |
| FY2022 | Dec 31, 2022 | -$146.53M | – |
| FY2021 | Dec 31, 2021 | -$148.46M | – |
| FY2020 | Dec 31, 2020 | -$69.69M | – |
| FY2019 | Dec 31, 2019 | -$36.51M | – |
| FY2018 | Dec 31, 2018 | -$1.02M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.84M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.93M | – |
| Q1 FY2026 | Mar 31, 2026 | -$15.65M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$14.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$62.73M | – |
| Q1 FY2025 | Mar 31, 2025 | -$84.93M | – |
| Q4 FY2024 | Dec 31, 2024 | -$63.46M | – |
| Q3 FY2024 | Sep 30, 2024 | -$63.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$70.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$69.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$43.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$31.91M | – |
| Q2 FY2023 | Jun 30, 2023 | -$22.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$39.67M | – |
| Q4 FY2022 | Dec 31, 2022 | -$41.04M | – |
| Q3 FY2022 | Sep 30, 2022 | -$35.02M | – |
| Q2 FY2022 | Jun 30, 2022 | -$25.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$44.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$41.26M | – |
| Q3 FY2021 | Sep 30, 2021 | -$29.07M | – |
| Q2 FY2021 | Jun 30, 2021 | -$28.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$49.77M | – |
| Q4 FY2020 | Dec 31, 2020 | -$28.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$20.73M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.42M | – |
| Q4 FY2019 | Dec 31, 2019 | -$23.38M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.11M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.21M | – |
| Q1 FY2019 | Mar 31, 2019 | -$807.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$302.00K | – |
See a number that looks wrong?